(Il Sole 24 Ore Radiocor) - Rome, Oct. 25 - Every day - reads the note - we observe interventions to reduce public spending that seriously endanger the quantity and quality of the services offered, undermining, in parallel, the competitiveness of key industrial sectors for the country's economy and development, primarily the pharmaceutical sector. With an annual production of 25 billion, an export of 61%, 2.4% of annual investments, 65,000 highly qualified employees, including 6,000 researchers, the sector is put to the test by a dangerous succession of corrective measures. It is estimated that the impact of these measures, between 2006 and 2010, was more than 11 billion euros to which a further two billion euros are added in the period 2012-2014 due to the Spending Review (contribution equal to 40% of the total of the budget against a weight of pharmaceuticals on health expenditure equal to approximately 16%)
If it is true that the recent Stability Law and the Balduzzi Decree introduce new cuts to public health, it is also true that the recipe for overcoming the crisis is not in linear cuts but in health planning and serious industrial policies, concludes the statement.
Com-gvb
(RADIOCOR) 25-10-12 16:10:48 (0416) 5 NNNN
Pharmaceutical. D'Ambrosio Lettieri (PDL): "The Government is committed to giving signals to the sector"
“The sector does not ask for money, only clear and equal rules for everyone”. For the senator, who spoke today at the Aschimfarma Forum, "a signal would be to respect the commitment undertaken with the approval of my agenda on the subject during the legislative process of the stability law”.
